<< Back

John H. Johnson
John has served as chairman of our board of directors since March 2015. He is a recognized leader in the biopharmaceutical industry with more than 30 years of experience at leading global organizations, including Johnson & Johnson, Eli Lilly & Company, ImClone, and Pfizer, Inc. He currently serves as executive chairman of VirMedica, lead independent director of Sucampo Pharmaceuticals, Inc., and as a member of the board of directors of Cempra Pharmaceuticals, Inc., Histogenics Corporation, and Portola Pharmaceuticals, Inc. John previously served on the board of directors of Pharmaceutical Research and Manufacturers of America (PhRMA), the Health Section Governing Board of Biotechnology Industry Organizations (BIO), and BioNJ.

John holds a BS from the East Stroudsburg University of Pennsylvania.

    © 2020 Strongbridge Biopharma plc
    STRONGBRIDGE BIOPHARMA® is a registered trademark of the Strongbridge Biopharma plc. companies, which include Strongbridge Dublin Limited and Strongbridge U.S. Inc.
    KEVEYIS® is a registered trademark licensed exclusively in the U.S. to Strongbridge Biopharma plc.
    MLR-0010 V16 03/2020

    • Ireland Address:
      Suite 206, Fitzwilliam Hall
      Fitzwilliam Place, Dublin 2, D02 T292
    • U.S. Address:
      900 Northbrook Drive, Suite 200
      Trevose, PA 19053
      United States

    Phone: +1 610-254-9200
    [email protected]

    Privacy Statement
    Compliance Program